跳至主要内容
临床试验/CTRI/2012/07/002759
CTRI/2012/07/002759
已完成
3 期

CABG Off or On Pump Revascularization Study (CORONARY) - CORONARY

Population Health Research Institute0 个研究点目标入组 4,700 人待定

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
Health Condition 1: I251- Atherosclerotic heart disease of native coronary arteryHealth Condition 2: null- Coronary artery disease
发起方
Population Health Research Institute
入组人数
4700
状态
已完成
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
2015年4月30日
最后更新
4年前
研究类型
Interventional

研究者

入排标准

入选标准

  • Patients who have been diagnosed with coronary artery disease (single, double or triple disease) will be eligible if they:
  • 1\.require isolated CABG with median sternotomy
  • 2\.are able to give their informed written consent
  • 3\.are above 21 years of age and
  • 4\.have one or more of the following risk factors:
  • â?¦above or equal to 70 years
  • â?¦peripheral vascular disease (previous peripheral bypass or amputation or ABI less than 0\.80\)
  • â?¦Cerebrovascular disease (history of stroke, TIA)
  • â?¦Renal insufficiency (creatinine above upper limit of normal)
  • â?¦above 60 years of age and one of the following:

排除标准

  • Patients will be excluded if they have one of the following:
  • 1\.concomitant cardiac procedure associated with CABG,
  • 2\.contra\-indications to off\-pump CABG or on\-pump CABG (calcified aorta, intramuscular LAD, calcified coronaries, small target vessels)
  • 3\.concomitant life\-threatening disease likely to limit life expectancy to less than 2 years,
  • 4\.prior enrollment in this trial
  • 5\.emergency CABG surgery (immediate revascularization for hemodynamic instability) OR
  • 6\.redo CABG.

结局指标

主要结局

未指定

相似试验